Search
for
Sort by
Research 391–420 of 473
- Alopecia in a Linear Pattern
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Alopecia areata - probing the deforestation
- Evaluating the combined efficacy of oral isotretinoin and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia—A randomized controlled trial
- Survey of pediatric dermatologist views on treatment for alopecia areata
- The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
- Severe hair loss induced by anthrax vaccine and reversed by the treatment with zinc
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- A trial of 1% minoxidil used topically for severe alopecia areata
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Compound Heterozygous Mutations in the Hairless Gene in Atrichia with Papular Lesions
- GENETIC CONTROL OF CYTOKINES
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Alopecia Areata: An Update on Treatment Options for Children
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- A “hair‐raising” history of alopecia areata
- Spanlastic Nano-Vesicles: A Novel Approach to Improve the Dissolution, Bioavailability, and Pharmacokinetic Behavior of Famotidine
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials